Best Health Care Stocks in 2019: Top 3 Health Care Stocks to Invest in 2019

Health care sector is one of the rare industries that don’t necessarily depend on the way economy is doing at a given time, which in a way makes it a safe haven for investors.

This s the case because people will always need medication and health care will always be in demand, as long as there are people who need it, and the case is that many people need their medications.

Health care is not infallible, meaning that shares from the sector of health care are still influenced by market trends, however, there are plenty of stable companies that would make solid and profitable investments.

Here are some of the top health care stocks to invest in 2019.

Best Health Care Stocks: Biogen (BIIB)

With a market cap of 65.2 billion dollars and price to earnings forward ratio set at 11.5, analysts following the progress of Biogen shares consider that Biogen is a “buy” in 2019 in general consensus.

At the same time Biogen is the third largest company by market capitalization among biotech companies on S&P 500. The third quarter of 2018 brought 3.4 billion dollars in revenue with 1.7 billion in cash flow.

Biogen BIIB shares are thus some of the most profitable in the health care sector.

Best Health Care Stocks: Celgene (CELG)

Bristol-Myers Squibb is planning on acquiring Celgene at a share price higher than its initial share price recorded in May 2019, which is why Celgene is set to bring a double-digit return in percentage for 2019.

Celgene is operating with very popular medical treatments for cancer, blood disorders and immunity diseases, which is why it makes a valuable company while CELG shares are set to bring profits to investors.

Best Health Care Stocks: ANI Pharmaceuticals (ANIP)

ANI is managing to stay on the top of drug manufacturers with 206.1 million dollars in sales for 2018 with revenue rising by 14% over a year concluded with 2018.

Additionally, earnings per share for ANI Pharma jumped by 76% in the course of the last five years concluded with 2019. Analysts expect to see the shares rising as a consequence, deeming ANIP as bullish.


Disclaimer: The information on this site is provided for discussion purposes only, and should not be misconstrued as investment advice. Under no circumstances does this information represent a recommendation to buy or sell securities.